Hospital
Goshen Hospital Association INC
Goshen Hospital Association INC was paid $10.92M by Medicaid between Jan 2018 and Nov 2024, across 76 billing codes. Its largest line is 99284, emergency room visit (serious) — 36% of everything it billed.
33Billing provider infoGOSHEN HOSPITAL ASSOCIATION INC
GOSHEN, IN 46526
GOSHEN, IN 46526
33aNPI1740268846assigned 01/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.92M
24GClaims190,032
24DCodes billed76
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#33 of 69
Median peer was paid$9.76M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,658 | $534K | |
| 2019 | 19,416 | $796K | |
| 2020 | 17,383 | $901K | |
| 2021 | 30,146 | $1.88M | |
| 2022 | 35,474 | $2.42M | |
| 2023 | 37,366 | $2.45M | |
| 2024incomplete | 28,589 | $1.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 27,034 | 22,792 | $3.97M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 25,857 | 22,780 | $3.56M |
| 71045 | Radiologic examination, chest; single view | 10% | 8,695 | 7,569 | $1.13M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.5% | 5,539 | 4,641 | $385K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 5,665 | 4,875 | $343K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 3,869 | 812 | $341K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.1% | 1,730 | 1,426 | $232K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 2,419 | 2,149 | $169K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.3% | 990 | 364 | $144K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,714 | 2,405 | $106K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,878 | 20,875 | $100K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,216 | 15,067 | $77K |
64 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 89 | $54K |
| 36415 | Collection of venous blood by venipuncture | <1% | 23,532 | $44K |
| 80076 | <1% | 6,340 | $28K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 29 | $26K |
| 81002 | <1% | 9,169 | $18K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 116 | $17K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 116 | $16K |
| 80053 | Comprehensive metabolic panel | <1% | 3,022 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,159 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 212 | $12K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 31 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 86 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 435 | $10K |
| 81025 | <1% | 1,585 | $9K | |
| 87276 | <1% | 795 | $9K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 76 | $9K |
| 87275 | <1% | 795 | $7K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,164 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 45 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 55 | $5K |
| 83690 | <1% | 1,558 | $5K | |
| 84484 | <1% | 837 | $5K | |
| 83880 | <1% | 234 | $5K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 40 | $3K |
| 81001 | <1% | 2,810 | $3K | |
| 83735 | <1% | 920 | $3K | |
| 82550 | <1% | 652 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 86 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 162 | $2K |
| 71250 | <1% | 17 | $2K | |
| 88307 | <1% | 54 | $2K | |
| 87581 | <1% | 63 | $1K | |
| 87486 | <1% | 63 | $1K | |
| 87807 | <1% | 127 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 52 | $1K |
| 82077 | <1% | 76 | $821.16 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 40 | $688.48 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 112 | $605.25 |
| 80305 | <1% | 102 | $577.93 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 143 | $412.42 |
| 83615 | <1% | 129 | $333.52 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 31 | $326.32 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 63 | $315.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,572 | $301.14 |
| 88342 | <1% | 15 | $255.19 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12 | $248.56 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | $222.85 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 41 | $158.30 |
| 85610 | <1% | 58 | $138.45 | |
| 85730 | <1% | 40 | $134.09 | |
| 87081 | <1% | 30 | $45.01 | |
| 80069 | <1% | 33 | $40.34 | |
| J2704 | Injection, propofol, 10 mg | <1% | 188 | $37.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 126 | $37.28 |
| 80061 | Lipid panel | <1% | 25 | $32.28 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 153 | $31.17 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24 | $23.42 |
| 85014 | <1% | 13 | $8.14 | |
| 85018 | <1% | 13 | $8.13 | |
| 85027 | <1% | 18 | $2.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,563 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 57 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 76 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 135 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWINE, LISA (CHIEF FINANCIAL OFFICER)